Choi V M, Coates J E, Chooi J, Thomson A B, Russell A S
Department of Medicine, University of Alberta, Edmonton.
Clin Invest Med. 1995 Oct;18(5):357-61.
The baseline permeability of small bowel in 57 healthy volunteers was assessed by measuring the mannitol and chromium-EDTA recovery in a 5-hour urine collection after ingestion of a drink containing a mixture of 1 g of mannitol and 3.7 MBq of 51Cr-EDTA. Subjects were treated with medication for 1 week followed by permeability studies as described above. The regimens used were diclofenac sodium (Voltaren) 50 mg po tid (21 subjects), Voltaren SR 75 mg bid for 1 week (34 subjects), indomethacin 50 mg tid (10 subjects), and tenoxicam (Mobiflex) 20 mg daily (13 subjects). There was no significant difference between the mannitol recoveries at baseline or after any of the drugs. The permeability was clearly increased by indomethacin and by Voltaren SR. Conventional-release Voltaren increased permeability, but the results were not significantly above baseline. Mobiflex had no influence on the measured permeability. Our results suggest that the SR preparation of diclofenac has a more pronounced effect than regular diclofenac sodium; thus different NSAIDs and different preparations of the same NSAID may have different effects on small bowel permeability.
通过测量57名健康志愿者在摄入含有1克甘露醇和3.7兆贝克勒尔51铬-乙二胺四乙酸混合物的饮料后5小时尿液中甘露醇和铬-乙二胺四乙酸的回收率,评估小肠的基线通透性。受试者接受药物治疗1周,然后按照上述方法进行通透性研究。使用的治疗方案有双氯芬酸钠(扶他林)50毫克口服,每日三次(21名受试者),缓释扶他林75毫克,每日两次,共1周(34名受试者),吲哚美辛50毫克,每日三次(10名受试者),以及替诺昔康(莫比可)20毫克,每日一次(13名受试者)。在基线时或使用任何一种药物后,甘露醇回收率之间没有显著差异。吲哚美辛和缓释扶他林明显增加了通透性。普通释放型扶他林增加了通透性,但结果并未显著高于基线水平。莫比可对测得的通透性没有影响。我们的结果表明,双氯芬酸的缓释制剂比普通双氯芬酸钠具有更显著的效果;因此,不同的非甾体抗炎药以及同一非甾体抗炎药的不同制剂可能对小肠通透性有不同影响。